Ongoing research is exploring their potential role across a range of conditions, including cardiovascular disease prevention, metabolic liver disease, and addictions medicine
LUXuriously Lean R x Where Science Meets Slim
Starting our patients with semaglutide also allows us to evaluate how they respond to GLP-1 therapy alone before potentially introducing the additional GIP action with tirzepatide
JoHelen McClain, a 72-year-old real estate agent from suburban Oklahoma City, had a simple goal when she started taking Wegovy in November of 2023
After six months, participants in the GLP-1RA-treated group achieved significantly greater weight loss compared to the control group [98]
Lovshin JA, Barnie A, DeAlmeida A, et al